Cramer's Lightning Round - Revlimid Is Still a Miracle Drug (12/6/10)

by: Miriam Metzinger

Stocks discussed on the lightning round session of Jim Cramer's Mad Money TV Program, Monday December 6.

Bullish Calls:

Celgene (NASDAQ:CELG): "...was down big, I've gone over the data...I think this stock is going to come back. If they downgrade it tomorrow I would pull the trigger. Revlimid is a miracle drug; there is significant information that is postitive for Revlimid and not negative."

Meridian Biosciences (NASDAQ:VIVO), Becton Dickinson (NYSE:BDX): "I do like diagnostics....BDX is very, very cheap."

Donaldson (NYSE:DCI): "I like Donaldson. It is turning...I've been recommending that one for a long time."

Qwest (Q), CenturyTel (NYSE:CTL): (on news Qwest will merge with CTL): "I reiterate the buy (of Qwest)...I like CTL and I think it goes higher."

Warnaco (WRC): "If you want underwear...that story is terrific."

Bearish Calls:

Clorox (NYSE:CLX): "Bad...I got to tell you I am going to stick with it, but that was a disappointing quarter...they really let us down...that was hideous, but down here with that nice yield I can't back is too low. "

Genpact (NYSE:G): "I'm not going to give you a buy...I know the company pretty well...frankly I have no catalyst."

Micron Technology (NASDAQ:MU): "I say forget it...I would much rather have you in any internet tsunami names I've been recommending. "

Hanesbrands (NYSE:HBI): "I'm sending out of Hanes and into Warnaco."


Jim Cramer was up 31% in 2009. Click here now to sign up for Jim's Action Alerts PLUS and trade alongside him. Special discount for Seeking Alpha users.

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.